Carisma Therapeutics Inc. (CARM) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-11-18
1:31 pm
Purchase
2022-11-0913DSesen Bio, Inc.
SESN
Radoff Bradley Louis300,000
3.000%
300,000increase
(New Position)
Filing
History
2022-07-08
4:56 pm
Sale
2022-06-3013GSesen Bio, Inc.
SESN
BlackRock Inc.
BLK
204,433
2.000%
-469,997decrease
(-69.69%)
Filing
History
2022-02-10
08:37 am
Purchase
2021-12-3113GSesen Bio, Inc.
SESN
The Vanguard Group618,338
6.200%
618,338increase
(New Position)
Filing
History
2022-02-04
4:12 pm
Purchase
2021-12-3113GSesen Bio, Inc.
SESN
BlackRock Inc.
BLK
674,430
6.800%
674,430increase
(New Position)
Filing
History
2021-06-28
4:33 pm
Purchase
2021-06-1713GSesen Bio, Inc.
SESN
INTEGRATED ASSETS II LLC97,809
1.100%
97,809increase
(New Position)
Filing
History
Goto Prev, 0, 1